Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Oruka Therapeutics, Inc. (ORKA) had Return on Tangible Equity of -22.34% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-105.43M |
|
-- |
|
-- |
|
$122.05M |
|
$-122.05M |
|
$16.62M |
|
$-105.43M |
|
$-105.43M |
|
$-105.43M |
|
$-105.43M |
|
$-105.43M |
|
$-105.43M |
|
$-122.05M |
|
$-126.97M |
|
45.61M |
|
45.61M |
|
$-1.85 |
|
$-1.85 |
|
| Balance Sheet Financials | |
$343.86M |
|
$0.29M |
|
$144.76M |
|
$488.62M |
|
$15.37M |
|
-- |
|
$1.31M |
|
$16.69M |
|
$469.00M |
|
$471.93M |
|
$471.93M |
|
48.72M |
|
| Cash Flow Statement Financials | |
$-88.21M |
|
$-96.75M |
|
$170.31M |
|
$61.58M |
|
$46.94M |
|
$-14.64M |
|
$24.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-88.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.48% |
|
|
Return on Tangible Equity |
-22.34% |
-21.58% |
|
-22.34% |
|
$9.69 |
|
$-1.94 |
|
$-1.93 |
|